Alizé Pharma 3, a company specialized in developing therapeutic peptides for the treatment of rare endocrine and metabolic diseases, announced a key addition to its leadership team and the structuring of its product portfolio in line with its ambition to become a leading global rare disease company. Alizé Pharma 3 is the third venture…